← Eichor
Study identifier: NCT06609317 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Postpartum pElvic Assisted Recovery With Leva

Condition: Postpartum Pelvic Floor Function and Symptoms  ·  Sponsor: University of South Florida

PhaseNA
Planned participants25
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device. In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum. Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.

This description comes directly from the study's public registry record.

Talk to the study team

Katie Propst, MD  ·  813-259-0655  ·  katiepropst@usf.edu

Maha Al Jumaily, MBBS  ·  813-259-8680  ·  mahaaljumaily@usf.edu

Always discuss trial participation with your own doctor first.

Locations (2)

University of South FloridaTampa, Florida, United StatesRecruiting
Ohio State University Wexner Medical CenterColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06609317